Neil Dahiya

Praxis Precision Medicines, Inc., a biopharmaceutical firm in the clinical development phase, focuses on converting genetic knowledge into treatments for central nervous system (CNS) disorders marked by imbalances in neuron excitation and inhibition. The company has announced plans to present […]

Hutchmed (China) Limited, a forward-thinking biopharmaceutical firm in the commercial phase, has declared the continuation of Orpathys (savolitinib) in the updated National Reimbursement Drug List (NRDL), following the renewal agreement with China’s National Healthcare Security Administration (NHSA). Scheduled to come

Galderma, a key player in the dermatology field globally, has revealed the complete results of the phase III OLYMPIA 1 trial — a 24-week examination of nemolizumab’s effectiveness and safety in adults with moderate-to-severe prurigo nodularis — in JAMA Dermatology.

Zai Lab Limited, a pioneering biopharmaceutical enterprise engaged in research and commercialization, has disclosed an update pertaining to the inclusion of specific pharmaceuticals and their indications in the 2024 National Reimbursement Drug List (NRDL), as unveiled by the National Healthcare

Kane Biotech Inc. recently announced a new agreement where BioStem Technologies Inc. (BioStem) is set to acquire commercial products and development technologies from ProgenaCare Global LLC (ProgenaCare), Kane Biotech’s existing US distributor. This deal includes exclusive distribution rights in the

Bayer has recently opened its latest life science incubator, Bayer Co.Lab Berlin, strategically positioned on the Global Headquarters Campus of its Pharmaceuticals Division. This facility is proximal to prominent research and clinical institutions. MyoPax GmbH, a Berlin-based enterprise known for

Qiagen, a prominent international leader in Sample to Insight solutions, has unveiled two groundbreaking tools aimed at crafting and acquiring tailored solutions for microbial examination of bacterial, fungal, and viral entities. These innovative resources allow scientists to modify their assays

Boehringer Ingelheim, a leading name in the field of animal health, has recently introduced its latest vaccine, Eurican L4, to safeguard dogs against the escalating threat of leptospirosis, a severe and resurging infectious disease. Veterinary clinics in France can now

Surgical product imports into the nation have increased by 11.5% in the first half of the current financial year compared to the same timeframe in the previous year, with a 12.3% rise noted for the quarter concluding in September 2024.

To establish a clear scope for the Product Under Consideration (PUC) and Product Control Numbers (PCN) approach, ensuring precise and transparent analysis, the Directorate General of Trade Remedies (DGTR) is assessing the ongoing investigation into anti-dumping activities related to acrylonitrile